The DOI matches its Crossref record; 112 of the 114 references it cites were found in a registry or an index.
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinically, GLP-1 RAs are indicated for the treatment of type 2 diabetes (all) and obesity (liraglutide and semaglutide only) and have beneficial effects on patient-important outcomes such as weight loss, cardiovascular and kidney events, hepatic steatosis, and mortality.5,7–9,11,30”
From Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By contrast, modern treatment guidelines for type 2 diabetes 154 and essential hypertension 155 (also nutrition related chronic diseases), do recommend a stepped care approach to pharmacotherapy.”
From Effectiveness and safety of drugs for obesity (2024) · cites this paper as [154]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As a result, GLP-1 RAs are contraindicated for patients with a personal or family history of MTC or those with multiple endocrine neoplasia syndrome type 2.8,17,22”
From Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredIn the citing paper
“However, a 5% weight reduction is insufficient to improve many aspects of health, and greater weight losses confer greater benefits, 23,82,83 with some data suggesting that there may be a threshold effect for reduction in some important comorbidities such as CVD and diabetes remission.[84][85][86]”
From Approach to Obesity Treatment in Primary Care: A Review (2024) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Self-citationRiddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D’Alessio, D. A., & Davies, M. J. (2020) · Diabetes Care · doi:10.2337/dci19-0066 · Cited by 1,192
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 1,039
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Gerstein, H. C., Sattar, N., Rosenstock, J., Ramasundarahettige, C., Pratley, R., Lopes, R. D., Lam, C. S. P., Khurmi, N. S., Heenan, L., Del Prato, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108269 · Cited by 829
Self-citation
Flagged first, then by citations
2 of the 114 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Peters, 2013, American Diabetes Association/JDRF Type 1 Diabetes Sourcebook
Cited by
Sorted by citations
Items 301–400 of 852
Spasovski, G. B., Rroji, M., Hristov, G., Bushljetikj, O., Spahia, N., & Bushletikj, I. R. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0227 · Cited by 9
Cancer risk according to fasting blood glucose trajectories: a population-based cohort study
Khong, T. M. T., Bui, T. T., Kang, H., Lee, J., Park, E., & Oh, J. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003696 · Cited by 11
Peppas, S., Doumas, S., Suvarnakar, A. M., Chou, J., Arafat, A., Ahmad, A. I., & Lewis, J. H. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002754 · Cited by 9
Tan, L. T., McDermott, K. M., & Hicks, C. W. (2024) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2024.04.006 · Cited by 8
Nielsen, S. F., Duus, C. L., Buus, N. H., Bech, J. N., & Mose, F. H. (2024) · JMIR Research Protocols · doi:10.2196/56067 · Cited by 7
iGlarLixi for type 2 diabetes: a systematic review and meta-analysis
Liu, Y., Li, C., Li, X., Yang, J., Zheng, Y., Li, F., & Wang, X. (2024) · Endocrine · doi:10.1007/s12020-024-03868-3 · Cited by 8
SGLT2 Inhibition, Blood Lipids, and Cardiovascular Disease: A Mendelian Randomization Study
Li, J., Li, C., Feng, X., & Wei, X. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14987 · Cited by 8
Alenzi, S., Alzahrani, A., Aljaloud, A., Alanazi, K., & Alarfaj, S. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1395651 · Cited by 8
Area deprivation index impact on type 2 diabetes outcomes in a regional health plan
Laffey, T., Marr, D., Modany, A., McGraw, M., Mounarath, T., Bryk, A., Christian, N. J., & Good, C. B. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.12.1375 · Cited by 8
Garedow, A. W., Tesfaye, G. T., Tamrat, R., & Wynendaele, E. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01795-y · Cited by 9
Sun, M., Wang, X., Lu, Z., Yang, Y., Lv, S., Miao, M., Chen, W., Wu, S., & Zhang, J. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101655 · Cited by 10
Use and Interchange of Incretin Mimetics in the Treatment of Metabolic Diseases: A Narrative Review
Teague, M., Martinez, A., Walker, E., El-Rifai, M., & Carris, N. W. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.02.003 · Cited by 8
Samkari, M., Bokhari, N. S. A., Alhajaji, R., Ahmed, M. E., Raddadi, A. A., Bahget, A. K., Saleh, S. F., Aljehani, F., Alzahrani, S. H., Alsifyani, S. S., et al. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.04.022 · Cited by 8
Gu, X., Jiang, S., Yang, Y., & Li, W. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01251-2 · Cited by 11
Ribeiro, S. A. G., Pedrotti, M., Hespanhol, L. C., Balieiro, C. C. A., Paqualotto, E., Silva, R. R. E., Gauza, M. D. M., & de Sá, J. R. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100285 · Cited by 7
Cao, Y., Cao, S., Zhao, J., Zhao, J., Zhao, Y., & Liu, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1387993 · Cited by 7
Blood, A. J., Chang, L., Colling, C., Stern, G. M., Gabovitch, D., Zelle, D., Zacherle, E. W., Noone, J., Robar, C., Aronson, S., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.01.003 · Cited by 7
Sanna, D., Fadda, A., Casula, M., Palomba, G., Sini, M. C., Colombino, M., Rozzo, C., Palmieri, G., Gallo, C., Carbone, D., et al. (2025) · BioMetals · doi:10.1007/s10534-025-00673-x · Cited by 7
Su, Y.-C., Hsieh, P., Lai, E. C., & Lin, Y. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70051 · Cited by 7
Hoog, M. M., Vallarino, C. R., Maldonado, J. M., Grabner, M., Teng, C., Terrell, K. A., & Richard, E. L. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01794-9 · Cited by 8
Gelhorn, H. L., Osumili, B., Brown, K. E., Ross, M., Schulz, A., Fernandez, G., & Boye, K. S. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s401465 · Cited by 7
Wang, Y., Jiang, C., Dong, X., Chen, M., Gu, Q., Zhang, L., Fu, Y., Pan, T., Bi, Y., Song, W., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15596 · Cited by 7
Alão, S., Silva, T., Leite, A. P., do Rosário, M., Carvalho, C., Coelho, J., Ferreira, H. J., Ferreira, R., Abreu, J., Rosa, M., et al. (2024) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2024.04.011 · Cited by 7
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction
Palazzuoli, A., Severino, P., D’Amato, A., Myftari, V., Tricarico, L., Correale, M., Dattilo, G., Fioretti, F., & Nodari, S. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2507270 · Cited by 9
Petrova, L., Andreevska, K., Parvova, I., & Petkova, V. B. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e132148 · Cited by 8
Lin, D. S., Lee, J., Huang, K., Lin, T., & Lo, H.-Y. (2024) · Diabetologia · doi:10.1007/s00125-024-06257-7 · Cited by 10
Arutyunov, G. P., Drapkina, O. M., Kobalava, Z. D., Конради, А. О., Lopatin, Y. M., Nedogoda, S. V., Sychev, D. A., Ткачева, О. Н., Shestakova, M. V., Shlyakhto, E. V., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6074 · Cited by 8
Gao, L., Bian, F., Pan, T., Jiang, H., Feng, B., Jiang, C., Sun, J. M., Xiao, J., Yan, P., & Ji, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16014 · Cited by 7
Zhang, Y., Li, Z., & Hao, Y. (2025) · European journal of medical research · doi:10.1186/s40001-024-02241-4 · Cited by 9
Ma, D., Zhao, P., Gao, J., Suo, H., Guo, X., Han, M., Zan, X., Chen, C., Lyu, X., Wang, H., et al. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.03.002 · Cited by 7
Trends in Use of Sulfonylurea Types Among US Adults with Diabetes: NHANES 1999–2020
Shin, J., Echouffo-Tcheugui, J. B., Fang, M., Grams, M. E., & Selvin, E. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08067-w · Cited by 6
Abiru, N., Nakatsuji, Y., Noguchi, M., & Tsuboi, K. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2193393 · Cited by 7
McDaniel, C. C., Lo‐Ciganic, W., & Chou, C. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2023.12.004 · Cited by 8
Type 2 Diabetes: Etiology, Epidemiology, Pathogenesis, and Treatment
Burns, C., & Francis, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_34 · Cited by 11
Cui, Y., Yao, J., Qiu, X., Guo, C., Kong, D., Dong, J., & Liao, L. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01540-7 · Cited by 8
Rotkvić, P. G., Rotkvić, L., Đuzel, A., & Berković, M. C. (2024) · World Journal of Cardiology · doi:10.4330/wjc.v16.i8.448 · Cited by 7
Paradigm Shift in the Management of Metabolic Diseases—Next-Generation Incretin Therapy
Åhrén, B. (2023) · Endocrinology · doi:10.1210/endocr/bqad166 · Cited by 7
Tan, G. S. Q., Maro, J. C., Wang, S. V., Toh, S., Morton, J. I., Ilomäki, J., Wong, J., & Li, X. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae355 · Cited by 6
WANGNOO, S. K., Bhadada, S. K., Farishta, F., Naidu, G. G. J., Pattnaik, I., Manohar, K. N., Singh, K., Gupta, S. K., Bharath, H. S., & Ghosh, S. K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1528801 · Cited by 8
Klepser, N., Weber, E. S., Li, L., Fleischmann, K. E., Masharani, U. B., Park, M., Max, W. B., Yeboah, J., Hunink, M. G. M., & Ferket, B. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16619 · Cited by 6
Wei, Z., Xu, W., Wang, Y., Tian, Y., Wang, Z., Jing, S., Liu, W., Shen, S., Qin, C., Zhang, X., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02892-5 · Cited by 7
Blockbuster Medications for Obesity: A Primer for Nephrologists
Zeitler, E. M., Dabb, K., Nadeem, D., Still, C. D., & Chang, A. R. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.04.009 · Cited by 6
Lee, E. Y., Cho, J., Lee, W. J., Kim, N. H., Kim, J. H., & Lee, B. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110884 · Cited by 6
Fathi, A. E., Ganji, M., Boiroux, D., Bengtsson, H. L., & Breton, M. D. (2023) · IEEE Conference on Control Technology and Applications (CCTA) · doi:10.1109/ccta54093.2023.10253127 · Cited by 6
Cogle, S. V., Hutchison, A. M., & Mulherin, D. W. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.11073 · Cited by 6
Broeng‐Mikkelgaard, S., Brøsen, J. M. B., Kristensen, P. L., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1301931 · Cited by 6
Ehrhardt, N. M., Aroda, V. R., Galindo, R. J., Peters, A. L., & Shubrook, J. H. (2023) · Clinical Diabetes · doi:10.2337/cd23-0047 · Cited by 6
Self-citationAziz, F., Sternad, C., Sourij, C., Knoll, L., Kojzar, H., Schranz, A., Bürger, A., Sourij, H., & Aberer, F. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15409 · Cited by 6
Kirkman, M. S., Tripputi, M., Krause-Steinrauf, H. J., Bebu, I., AbouAssi, H., Burch, H. B., Duran-Valdez, E., Florez, H. J., Garvey, W. T., Hsia, D. S., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1332 · Cited by 6
Dehghani, M., Sadeghi, M., Barzkar, F., Maghsoomi, Z., Janani, L., Motevalian, S. A., Loke, Y. K., Ismail‐Beigi, F., Baradaran, H. R., & Khamseh, M. E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1286827 · Cited by 9
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative Review
Cavallo, M., Fano, M. D., Barana, L., Dozzani, I., Bianchini, E., Pellegrino, M., Cisternino, L., Migliarelli, S., Giulietti, C., Pippi, R., et al. (2024) · Nutrients · doi:10.3390/nu16060907 · Cited by 9
Lentine, K. L., Miyata, K. N., Lam, N. N., Joseph, C., McAdams‐DeMarco, M., Bae, S., Chen, Y., Çalışkan, Y., Sarabu, N., Dhindsa, S., et al. (2024) · Clinical Transplantation · doi:10.1111/ctr.15257 · Cited by 6
Ray, S., Ezhilan, J., Karnik, R. D., Prasad, A., & Dhar, R. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_19_24 · Cited by 7
Palecek, E. J., Kimzey, M. M., Zhang, J., Marsden, J. E., Bays, C., Moran, W. P., Mauldin, P. D., & Schreiner, A. D. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241270427 · Cited by 6
Mukherjee, S., Mukherjee, S., Kwok, C. S., & Phillips, A. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i8.1120 · Cited by 6
Witek, P., Bolanowski, M., Kretowski, A. J., & Głowińska, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1455465 · Cited by 6
Costa, S., Miranda, C., Elefante, A., Vallone, V., Vinci, C., Borroni, F., Brandoni, G., Labate, A. M. M., Pomo, F. L., & Strazzabosco, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16314 · Cited by 6
Jacobsen, S. L., Köhler‐Forsberg, O., Danielsen, A. A., & Rohde, C. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116592 · Cited by 6
Yeggalam, A., Liebich, J. A., Yu, K. K., Shrestha, E., Nadella, S., Ahir, V., Newman, J., Lentine, K. L., Çalışkan, Y., Rub, F. A. A., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15035 · Cited by 6
Aldhaeefi, M., Beers, B., Shah, J., Rizi, S. S., Rungkitwattanakul, D. “., Nimoh, O., Frimpong, V., Gonzalez, J., Belrhiti, S., Fatima, U., et al. (2023) · Pharmacy · doi:10.3390/pharmacy11020058 · Cited by 6
Yarlagadda, C., Abutineh, M., Reddy, A. J., Landau, A. B., Travis, L. M., Perrone, C. G., Idriss, A., & Patel, R. P. (2023) · Cureus · doi:10.7759/cureus.36438 · Cited by 6
Kudo, A., Machii, N., Ono, T., Saito, H., Oshiro, Y., Takahashi, R., Oshiro, K., Taneda, Y., Higa, M., Nakachi, K., et al. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003302 · Cited by 6
Tsai, Y., Wu, C., Hung, W., Yu, P.-S., Liu, C.-C., Hsieh, T., Chen, C., Li, S.-S., Chen, J.-J., Chiu, Y.-W., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121883 · Cited by 6
Barouti, A. A., Björklund, A., Catrina, S., Brismar, K., & Ekberg, N. R. (2023) · Nutrients · doi:10.3390/nu15143092 · Cited by 6
Boye, K. S., Sapin, H., Dong, W., WILLIAMSON, S. E., Lee, C. J., & Thieu, V. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01457-7 · Cited by 8
Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes
Vázquez, L. A., Romera, I., Santos, M. R., & Escalada, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01467-5 · Cited by 7
Akkuş, E., Canpolat, A. G., Demir, Ö., Çorapçıoğlu, D., & Şahi̇n, M. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03798-5 · Cited by 6
Addressing Insulin Injection Technique: A Follow-up Study of Canadian Patients with Diabetes
Bari, B., Corbeil, M.-A., Macneill, G., Puebla-Barragan, S., & Vasquez, A. R. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01479-1 · Cited by 8
McDaniel, C. C., Lo-Ciganic, W.-H., Huang, J. L., & Chou, C. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02259-1 · Cited by 6
Cherrington, A., Tripputi, M., Younes, N., Herman, W. H., Katona, A. M., Groessl, E. J., Craig, J., Gonzalez, J. S., Garg, R., Casula, S., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1648 · Cited by 6
As, A., Шохин, И. Е., Rogozhina, E. A., Геннадьевна, Б. Т., Nevretdinova, M. E., Bely, P. A., Zaslavskaya, K. Y., Shcherbakova, V. S., Куркин, Д. В., Koryanova, K. N., et al. (2024) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2023-11-4-324-346 · Cited by 8
A Practical Guide to Understanding and Treating Peripheral Artery Disease
Chilbert, M. R., Woodruff, A. E., & Rogers, K. C. (2024) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001556 · Cited by 6
Cao, Y., Zhao, J., Ma, Y., Cao, S., & Ying, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s472968 · Cited by 6
Tan, X., Liang, Y. M., Gamble, C. L., & King, A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01509-y · Cited by 5
The pursuit of optimal semaglutide dosing in type 2 diabetes continues
Sherrill, C. H., & Hwang, A. Y. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01233-3 · Cited by 5
Li, J., Tian, Y., Li, L., Zhao, Y., Yang, S., Xu, W., Zhu, D., Ye, J., Chen, J., Liu, W.-T., et al. (2025) · MedComm · doi:10.1002/mco2.70094 · Cited by 5
Li, Y., Kar, S., Li, C., Liu, M. R., Luan, Z., Yuan, G., Zhong, X., & Mu, Y. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01701-2 · Cited by 5
Jiménez-López, R., Martín-Chaves, L., Gutiérrez-García, Á. M., Carmona-Segovia, A. D. M., Mora-Ordóñez, B., García, A. M. S., Fernández-Romero, L., Murri, M., Sanchez‐Quintero, M. J., García, G. B., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1631334 · Cited by 7
Larose, S., Filliter, C., Platt, R. W., Yu, O. H. Y., & Filion, K. B. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15106 · Cited by 6
Builes-Montaño, C. E., Wandurraga-Sánchez, E. A., Ramírez, Á., & Ordóñez, J. E. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01471-9 · Cited by 5
Mostaza, J. M., Pintó, X., Armario, P., Masana, L., Real, J. T., Valdivielso, P., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2024) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2024.02.001 · Cited by 14
Conceptualizing Treatment Burden among People with Type 2 Diabetes
Bitterfeld, L., & Reed, S. M. (2024) · Nursing Forum · doi:10.1155/2024/9974083 · Cited by 5
Alfakhri, A., Almadani, O. A., Althunian, T. A., Alrwisan, A. A., Badreldin, H. A., & Albogami, Y. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111770 · Cited by 5
Zainudin, A. M., Rasool, A. H. G., Yaacob, N. M., Muhamad, R., & Mohamed, W. M. I. W. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01577-6 · Cited by 5
Zhu, J., Wilding, J. P. H., & Gu, X. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i10.2135 · Cited by 8
The effect of SGLT2 inhibitor in patients with type 2 diabetes and atrial fibrillation
Cho, Y., Shin, S., Park, M.-A., Suh, Y. J., Park, S., Jang, J.-H., Kim, D.-Y., & Kim, S. H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0314454 · Cited by 6
Li, Z., Luo, D., & Li, Z. (2025) · Endocrine Connections · doi:10.1530/ec-24-0576 · Cited by 5
Rajab, A. M., Pearson, S. M., & Ajjan, R. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16332 · Cited by 6
GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization
Franchini, L., Porter, J. J., Lueck, J. D., & Orlandi, C. (2025) · Nature Communications · doi:10.1038/s41467-025-59850-8 · Cited by 5
Chaichana, U., Man, K. K. C., Ju, C., Makaronidis, J., & Wei, L. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf429 · Cited by 5
Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review
Valencia-Morales, N. D., Cubillo, B. R., Loayza-López, R. K., de la Higuera, M. Á. M., & Sánchez-Fructuoso, A. I. (2023) · Life · doi:10.3390/life13061265 · Cited by 5
Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases
Miyazaki, R., & Miyagi, K. (2023) · Renal Replacement Therapy · doi:10.1186/s41100-023-00492-1 · Cited by 5
Mita, T., Katakami, N., Yoshii, H., Onuma, T., Kaneto, H., Osonoi, T., Shiraiwa, T., Yasuda, T., Umayahara, Y., Yamamoto, T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41036-1 · Cited by 5
Management of Type 2 Diabetes Mellitus
Kawa, L. B. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002478 · Cited by 6
Stewart-Lynch, A. L., Meyers, R., Sidig, D., McConville, S.-O., & Heiple, L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0044 · Cited by 5
Kawahara, J., Kaku, B., Yagi, K., Kitagawa, N., Yokoyama, M., Wakabayashi, Y., Senda, S., Takata, H., & Hiraiwa, Y. (2023) · Diabetology International · doi:10.1007/s13340-023-00664-8 · Cited by 5
Trueman, C., Shin, E. H., Donovan, A., McAdam‐Marx, C., & Coan, C. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.12.1275 · Cited by 6
Arnold, J., Idalsoaga, F. J., Díaz, L. A., Cabrera, D., Francisco Barrera, M., Arab, J. P., & Arrese, M. A. (2024) · Current Hepatology Reports · doi:10.1007/s11901-023-00629-0 · Cited by 5
Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes
Singh, S. T., Garg, A., Tantry, U. S., Bliden, K. P., Gurbel, P. A., & Gulati, M. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.02.039 · Cited by 5
Tabák, Á. G., Kempler, P., Guja, C., Eldor, R., Haluzı́k, M., Klupa, T., Παπάνας, Ν., Stoian, A. P., & Mankovsky, B. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01556-z · Cited by 5
Metadata
- Authors
- ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
- ORCID
- ElSayed, Nuha A.
- Aleppo, Grazia
- Aroda, Vanita R.
- Bannuru, Raveendhara R.
- Brown, Florence M.
- Bruemmer, Dennis
- Collins, Billy S.
- Hilliard, Marisa E.
- Isaacs, Diana
- Johnson, Eric L.
- Kahan, Scott
- Khunti, Kamlesh
- Lyons, Sarah K.
- Perry, Mary Lou
- Prahalad, Priya
- Pratley, Richard E.
- Seley, Jane Jeffrie
- Stanton, Robert C.
- Gabbay, Robert A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-12-12
- Volume
- 46
- Issue
- Supplement_1
- Pages
- S140-S157
- ISSN
- 0149-5992 (ISSN-L)
- PMC
- PMC9810476
- OpenAlex
- W4311264067
- Semantic Scholar
- f75bf88f7fa4c4c0cf940dad739ba96bb6d15d64
- Cited by
- 851
- References
- 114
- Citations by year
- 2026: 64 · 2025: 149 · 2024: 360 · 2023: 277 · 2022: 1
- FWCI
- 28.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic control, pharmacotherapy, diabetes mellitus, antidiabetic drugs, clinical guidelines, treatment goals, quality of care
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
